Do you know about - Following PROTECT AF: The next-generation Watchman device in patients with AF
Causes Of Afib ! Again, for I know. Ready to share new things that are useful. You and your friends. What I said. It isn't outcome that the real about Causes Of Afib . You check out this article for info on a person need to know is Causes Of Afib .How is Following PROTECT AF: The next-generation Watchman device in patients with AF
Following PROTECT AF: The next-generation Watchman device in patients with AF Tube. Duration : 12.85 Mins.We had a good read. For the benefit of yourself. Be sure to read to the end. I want you to get good knowledge from Causes Of Afib . Results of the Embolic Protection in Patients with Atrial Fibrillation (PROTECT-AF) trial showed that in AF patients who were candidates for warfarin therapy, device closure of the left atrial appendage using the Watchman device was associated with a reduction in hemorrhagic stroke risk vs warfarin, and all-cause stroke and all-cause mortality outcomes were noninferior to warfarin. Safety events, however, particularly pericardial effusion, were more common in the device group. Dr Juan Viles-Gonzalez talks to Dr Vivek Reddy about the evolution of the procedure and the device, what he hopes to learn from EVOLVE and PREVAIL, and the future of LAA closure in a brave new world of novel anticoagulants
0 comments:
Post a Comment